Lucid Diagnostics Inc. (LUCD): Cash & Equivalents

Annual figures by period end, from SEC filings.

$22.36M
As of 2024-12-31
-25.3%
3-year compound annual growth
$53.66M2021-12-31: $53.66M2022-12-31: $22.47M2023-12-31: $18.90M2024-12-31: $22.36M$22.36M
2021-12-31 Cash & Equivalents (USD) 2024-12-31
Period endedCash & EquivalentsChange YoYSource filing
2024-12-31$22.36M+18.3%2025-03-24, Balance as of period end
2023-12-31$18.90M-15.9%2025-03-24, Balance as of period end
2022-12-31$22.47M-58.1%2024-03-25, Balance as of period end
2021-12-31$53.66Mn/a2023-03-14, Balance as of period end